4.8 Article

Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread

Journal

NUCLEIC ACIDS RESEARCH
Volume 50, Issue 1, Pages 333-349

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkab1248

Keywords

-

Funding

  1. Bavarian State Government by the Forderprogramm Corona-Forschung
  2. Else Kroener-Research College 'Microbial triggers as cause of disease'
  3. Volkswagen Foundation
  4. ERC starting grant [ERC-StG 637830]
  5. ERC consolidator grant [817798]
  6. German Research Foundation [PI1084/5, TRR178/TP11, TRR 237/A07]
  7. German Federal Ministry of Education and Research (COVINET)
  8. German Academic Exchange Service (DAAD)
  9. European Research Council (ERC) [817798] Funding Source: European Research Council (ERC)

Ask authors/readers for more resources

Small interfering (si)RNAs could be a promising approach to tackle SARS-CoV-2. Research shows that siRNAs can target the genomic RNA (gRNA) of the virus after cell entry, thereby terminating replication before transcription starts and preventing virus-induced cell death. Targeting common sequences shared by viral transcripts allows simultaneous suppression of gRNA and subgenomic (sg)RNAs, while specifically targeting the gRNA, especially open reading frame 1(ORF1), leads to the most effective suppression of viral replication and spread.
A promising approach to tackle the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) could be small interfering (si)RNAs. So far it is unclear, which viral replication steps can be efficiently inhibited with siRNAs. Here, we report that siRNAs can target genomic RNA (gRNA) of SARSCoV-2 after cell entry, and thereby terminate replication before start of transcription and prevent virus-induced cell death. Coronaviruses replicate via negative sense RNA intermediates using a unique discontinuous transcription process. As a result, each viral RNA contains identical sequences at the 5' and 3' end. Surprisingly, siRNAs were not active against intermediate negative sense transcripts. Targeting common sequences shared by all viral transcripts allowed simultaneous suppression of gRNA and subgenomic (sg)RNAs by a single siRNA. The most effective suppression of viral replication and spread, however, was achieved by siRNAs that targeted open reading frame 1 (ORF1) which only exists in gRNA. In contrast, siRNAs that targeted the common regions of transcripts were outcompeted by the highly abundant sgRNAs leading to an impaired antiviral efficacy. Verifying the translational relevance of these findings, we show that a chemically modified siRNA that targets a highly conserved region of ORF1, inhibited SARS-CoV-2 replication ex vivo in explants of the human lung. Our work encourages the development of siRNA-based therapies for COVID-19 and suggests that early therapy start, or prophylactic application, together with specifically targeting gRNA, might be key for high antiviral efficacy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available